NHS Trial Links Aspirin Use With Reduced Mortality Risk Among Women
This article was originally published in The Tan Sheet
Executive Summary
Results from the Nurses' Health Study showing significant reductions in risk of cardiovascular and other mortality associated with aspirin use do not outweigh existing clinical evidence to the contrary, an accompanying editorial by John Baron, M.D., Dartmouth Medical School, Lebanon, N.H., states in the March 26 Archives of Internal Medicine
You may also be interested in...
Aspirin Lowers Stroke, Not CV Risk In Women – NEJM Study
Study results showing low-dose aspirin reduces the risk of stroke in older women provide manufacturers with a targeted marketing message for a key patient group
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: